Genzyme Sold To Sanofi-Aventis In $20 Billion DealCambridge-based biotechnology company Genzyme is being bought by French drug maker Sanofi-Aventis for $20.1 billion, ending months of corporate haggling.

More From CBS Boston

Download Our App
Download Weather App
Taz Show

Listen Live